Additionally, our lab demonstrated that suppressed IGF-1R protein expression via miR-497 up-regulation was able to re-sensitize pancreatic cancer cells to gemcitabine and that plasma IGF-1R can discriminate pancreatic cancer from other pancreatic tumors [64]. Here, IGF1R is linked to pancreatic neoplasm.